Lancet (2021) 398(10296):26276
Non-GLP-1 options For people who cannot tolerate GLP-1 medications or prefer a different approach, other evidence-based options exist
Combination with Other Treatments: Peptide therapy can complement other weight loss treatments, such as diet plans and exercise regimens
On the other hand, administration of tirzepatide at a dose of 70 nmol/kg/day, resulted in a significant weight loss associated with shorter femur compared to saline-treated diabetic mice, but no evident alterations of bone microarchitecture or strength [69]
Obes (silver Spring Md,)
Our provider, Allison Page, NP-C, works closely with every patient to make sure youre supported, encouraged, and never left guessing